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Abstract 
 
Endothelial cells coat all the blood vessels, being essential for blood pressure 
regulation, blood coagulation, adhesion and transmigration of inflammatory cells from 
the vessels into the target tissue, and angiogenesis1,2. Although their properties and 
functions vary somewhat between species, organs, and depend on the location, size 
and type of vessel1,3, all endothelial cells support the needs of the various adjacent 
cells and microenvironments. They are potential producers of angiocrine factors that 
are endothelial-derived factors with paracrine effects4.  
Among other molecules, microRNAs (miRNAs or miRs) regulate several biological 
processes in cells, including in endothelial cells. MicroRNAs are endogenous, single 
strand, non-coding short ribonucleic acid molecules (about 22 nucleotides) that 
regulate gene expression at post-transcriptional level. These molecules silence gene 
expression through binding to the target mRNA, inhibiting its translation into proteins 
or promoting mRNA degradation. MiRNAs present an important tissue- and cell-type-
specific pattern and, by modulating gene expression, they may interfere with 
important processes such as apoptosis, cell proliferation and angiogenesis5. 
MiR-21 is an oncomiR, a miRNA that acts like an oncogene. It belongs to the 
specific miRNA signature of the vasculature6 and is overexpressed in various solid 
tumors7. It is described that this particular molecule is involved in cell survival, 
proliferation, motility, invasion, metastasis and chemoresistence7,8. However, its role 
in bone marrow remains to be elucidated. 
Aiming to evaluate the role of miR-21 in the bone marrow microenvironment 
and in bone marrow endothelial cells in particular, miR-21 expression was investigated 
on bone marrow cells. Moreover, the modulation of miR-21 levels in endothelial cells 
and the gene expression analysis through real-time quantitative polymerase chain 
reaction (RT-qPCR) allowed the identification of downstream targets underlying miR-
21 regulation of angiogenesis. Bioinformatic tools and literature allowed the choice of 
9 predicted targets, from which phosphatase and tensin homolog (PTEN) and Sprouty2 
were confirmed to be regulated by miR-21. Phenotypic changes modulated by miR-21 
levels were also assessed, indicating that miR-21 promotes tubulogenesis in the 
presence of vascular endothelial growth factor or basic fibroblast growth factor. 
 
Key words: endothelial cell, angiogenesis, miRNA, miR-21 
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Resumo 
 
As células endoteliais revestem os vasos sanguíneos, apresentando um papel 
essencial na regulação da pressão arterial, na coagulação do sangue, na adesão e 
transmigração de células envolvidas no processo inflamatório do lúmen dos vasos para 
o tecido alvo, e na angiogénese1,2. Apesar da heterogeneidade das suas propriedades e 
funções entre espécies, órgãos, e dependendo da localização, tamanho e tipo de vaso 
sanguíneo1,3, todas as células endoteliais apoiam as necessidades das células 
adjacentes e do microambiente que as rodeia. São potenciais produtoras de factores 
angiócrinos, que são factores derivados das células endoteliais com actividade 
parácrina4. 
Entre outras moléculas, os microRNAs (miRNAs ou miRs) regulam vários 
processos biológicos, actuando ao nível das células, nomeadamente das células 
endoteliais. Os microRNAs são pequenas moléculas de ácido ribonucleico de cadeia 
única não codificante (cerca de 22 nucleótidos), que regulam a expressão génica ao 
nível pós-transcripcional. Estas moléculas endógenas inibem a expressão génica 
ligando-se ao mRNA alvo, impedindo a sua transcrição em proteínas ou promovendo a 
sua degradação. Os miRNAs apresentam um padrão específico consoante o tipo de 
célula ou tecido e, através da modulação da expressão génica, podem interferir com 
importantes processos biológicos, tais como a apoptose e proliferação celulares e a 
angiogénese5. 
O miR-21 é um oncomiR, isto é, um miRNA que actua como oncogene. Pertence 
à assinatura de miRNAs específica do sistema vascular6 e está sobrexpresso em vários 
tumores sólidos7. Esta molécula em particular está descrita como estando envolvida na 
sobrevivência, proliferação e mobilidade celular, bem como nos processos de invasão, 
metástase e resistência à quimioterapia7,8. Contudo, o seu papel na medula óssea 
continua por esclarecer. 
Com o objectivo de avaliar o papel do miR-21 no microambiente da medula 
óssea e nas células endoteliais da medula óssea em particular, a expressão do miR-21 
foi estudada nas células da medula óssea. Além disso, através da modulação dos níveis 
do mir-21 nas células endoteliais e a análise da expressão génica por reacção em 
cadeia da polimerase em tempo real quantitativa (RT-qPCR) permitiram a identificação 
de possíveis alvos do miR-21 envolvidos na regulação da angiogénese. A utilização de 
ferramentas bioinformáticas em conjunto com a literatura facilitou a escolha de 9 
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possíveis alvos, dos quais PTEN e Sprouty2 demonstraram ser regulados pelo mir-21. 
Alterações fenotípicas derivadas da regulação deste miRNA também foram analisadas 
e indicam que miR-21 promove a tubulogénese na presença do factor de crescimento 
endotelial vascular e do factor de crescimento fibroblástico básico. 
  
Palavras chave: células endoteliais, angiogénese, miRNA, miR-21 
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Introduction 
 
Blood vessels and endothelial cell properties 
 
The circulatory system is the first to develop during the vertebrate gestation, to 
guarantee the delivery of nutrients and oxygen and to assure the removal of metabolic 
waste from all the cells and tissues of the growing embryo. While the embryo grows 
through cell differentiation and morphogenesis, also the vasculature spreads out, 
remodels and differentiates into different types of blood vessels1. 
The first stage of vascular development, vasculogenesis, begins after 
gastrulation, with de novo emergence of primordial endothelial cells from the 
coalescence of blood islands of the mesoderm, in the extraembryonic yolk sac, to form 
a primary vascular plexus. Afterwards, this vascular plexus remodels to form a highly 
differentiated circulatory network, through angiogenesis, the process by which new 
blood vessels sprout from preexisting ones1. 
 
1. Blood vessels 
 
Blood vessels are highly organized and complex structures, proficient to control 
blood flow. Their integrity is assured by endothelial cells, pericytes, smooth muscle 
cells, fibroblasts, glial cells and inflammatory cells and by the extracellular matrix 
(ECM), which bears the constant mechanical forces exerted by the blood flow, controls 
the proliferation and differentiation of the vascular cells and modulates the effects of 
growth factors1,9. Blood vessels may be subdivided into 3 main interconnected types, 
differing in structure and function1,10,11: 
1. The arteries that have the vital function of conducting oxygenated blood all over 
the body, with the exception of the pulmonary arteries that carry deoxygenated 
blood to the lungs. They are constituted by an inner monolayer (tunica intima) of 
endothelial cells, a middle layer (tunica media) of thick connective tissue with 
elastin filaments and smooth muscle cells, and an outer layer (tunica adventitia) 
of fibrous connective tissue, containing fibroblasts, parasympathetic nerves, that 
foster the smooth muscle of the middle layer to sustain the high blood pressure, 
and collagen, that supports the vessel and links it to the surrounding tissues. All 3 
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layers are separated by elastic lamina and have collagen in their constitution, 
acting like an anchor to all the cells. Arteries have narrow lumen, contributing to 
the optimal blood flow. When they reach organs, they divide themselves into 
smaller vessels, the arterioles, which in turn give rise to capillaries by division as 
well10,11. 
2. The capillaries that are the tiniest vessels, composed only by a single cell layer of 
endothelial cells surrounded by a basal lamina consisting mostly of type IV 
collagen. At this level, there is very low blood pressure to allow the gaseous and 
nutritional exchange between capillaries and tissue fluids. The precapillary 
sphincters, bands of smooth muscle around arterioles, control the quantity of 
blood flowing into a capillary10,11. 
3. The veins that, with the exception of the pulmonary ones, carry the 
deoxygenated blood from the organs back to the heart. They are also composed 
by three layers similar to arteries, but they have a much thinner middle muscular 
layer and a much larger lumen. Besides, they are fitted with one-way valves, 
derived from the endothelium, to prevent the backflow of blood, due to the tiny 
blood pressure in these vessels10,11. 
 
2. Endothelial Cells 
 
Therefore, all the blood vessels are coated by endothelial cells that are essential 
for blood pressure regulation, blood coagulation, adhesion and transmigration of 
inflammatory cells from the vessels into the target tissue, and angiogenesis1,2. 
Endothelial cells properties and functions vary somewhat between species, 
organs, and depend on the location, size and type of vessel1,3. All endothelial cells are 
highly metabolically active and have different phenotypes, supporting the needs of the 
various adjacent cells and microenvironments. However, they are usually thin and 
slightly elongated along the axis of the vessel, reducing the shear stress forces of the 
flowing blood3. 
The development and maintenance of the endothelium requires the 
establishment of a dynamic equilibrium between physical forces (e.g. tension, 
compression or shear stress), polarity, adhesion and permeability12. In addition, as 
described below, endothelial cell number and function is also tightly regulated by the 
action of pro- and anti-angiogenic growth factors. The quiescence of the adult normal 
vasculature is maintained by the tight equilibrium between these angiogenic 
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promoters and inhibitors, respectively. Pro-angiogenic factors like angiopoietins, basic 
fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) promote 
angiogenesis, inducing cell survival and migration. Anti-angiogenic factors, such as 
thrombospondins (TSPs), angiostatin and endostatin, suppress migration and induces 
apoptosis of endothelial cells. The disruption of this angiogenesis balance might result 
in physiological angiogenesis, such as wound healing, or in pathological angiogenesis, 
such as tumor angiogenesis1,13,14. 
 
2.1. Endothelial Cell Polarity 
 
The polarity of the endothelium is defined by different phosphoinositides and 
protein complexes in apical and basolateral regions, corresponding to luminal and 
abluminal membranes, respectively. Modulation cell polarity occurs through changes 
in cell-cell junctional molecules. Par3, Par6 and atypical protein kinase C (aPKC) are the 
crucial proteins to this process. Par3 is associated to cell-to-cell junctions, while Par6 
and aPKC defines the apical region. Crumbs and Scribble assure the stabilization of 
apical and basolateral domains, respectively, through their combination with the Par 
proteins. All these complexes associated to polarity are decisive for lumen formation 
as well12,15.  
 
2.2. Endothelial Cell Adhesion 
 
Endothelial cells form a crucial selective semi-permeable barrier between the 
vessel lumen and the surrounding tissue, controlling the transport of small molecules, 
macromolecules and cells and the degradation of lipoprotein particles1,2. These barrier 
functions are highly dependent on the type of cell adhesion molecules (CAMs) that 
delineate cell borders, either cell-cell adhesions, which assure the barrier function, or 
cell-matrix adhesions, which assure barrier integrity (Figure 1)16. 
The major families of CAMs are cadherins, selectins, integrins and Ig-superfamily 
CAMs. Cadherins form homodimers, cluster together and their activity is calcium-
dependent. Selectins form homodimers as well and their lectin domains recognize 
specialized sugar structures on glycoproteins on adjacent cells. Integrins form 
heterodimers and bind to very large multiadhesive matrix proteins, such as fibronectin, 
supporting the cell anchorage to collagen and proteoglycans. Ig-CAMs, in turn, do not 
form dimmers, but may have both homophilic and heterophilic interactions. Many 
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adhesion molecules interact with the cytoskeleton through adapter proteins, providing 
mechanical continuity among cells and allowing mechanical resistance to disruption. 
Thereby, these interactions are not only adhesive, but they also facilitate 
communication between cells and microenvironment16. 
All these CAMs are on the basis of the different types of connecting junctions 
that bind the cells together17. 
1. Gap junctions connect both cytosols joining two connexon hemichannels, 
constituted by six connexin molecules. The formed pore is very selective, only 
allowing water, ions, and small molecules to pass through. Thus, cell 
communication is the main function of this type of joint17.  
2. Tight junctions do not allow transition of large molecules through the 
extracellular space between the endothelial cells, sealing a barrier. They also 
sustain the polarity of these cells by preventing the diffusion of membrane 
proteins and glycolipids between the apical and the basolateral regions, 
maintaining different lipid composition of the two regions. Occludin, claudin and 
junction adhesion molecule (JAM) are the main proteins found in tight junctions. 
They combine with actin filaments, controlling solute flow and cell signaling17. 
3. Anchoring junctions attach cells mechanically within the tissue and to the ECM. 
Several types of these junctional complexes serve this function: 
2.2. Adherent junctions are carried out by cadherins, which binds to p120-
catenin and β-catenin, which interacts with α-catenin, which, in turn, binds 
to F-actin. Adherent junctions tie cells not only to other cells, but also to 
the ECM and, simultaneously, they act as a signaling platform17,18. 
2.3. Desmosomes are similar to adherent junctions, although they bind to 
intermediate filaments. They are composed by desmoglein and 
desmocollin, transmembranar proteins that belong to cadherin family, and 
they also require attachment to a cytoplasmic plaque. The cytoplasmic 
plaque is formed by plakoglobin, desmoplakins and plakophilins that are 
structures similar to α-catenin and β-catenin. Desmosomes confer strength 
and durability to the cells17. 
2.4. Hemidesmosomes, in contrast to all the other types of junctions, are 
involved only in the anchorage of the cells to the ECM through the 
attachment of integrins to specific ligands, like ECM proteins, such as 
fibronectin, fibrinogen, vitronectin, and collagen. This interaction manages 
cell shape, rigidity and signaling18,19. 
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2.2.1. Cell-to-cell Junctions 
 
Endothelial cells are joined together by transmembranar adhesive proteins that, 
beyond the adhesion function, are responsible for intercellular recognition and might 
indirectly regulate transcriptional activity, once they may transmit several signals to 
the cell, controlling several physiological features. These molecules must be very 
dynamic to allow leukocyte transmigration during inflammation and cellular 
remodeling during angiogenesis, confining paracellular permeability20. 
Cell-to-cell connections are maintained essentially by tight junctions and 
adherent junctions, with specific positions in the junctional cleft. The tight junctions 
cover the most apical position, sealing the cleft limits on the way to the luminal 
surface. The adherent junctions, in turn, are localized more basally, sustaining the 
morphology and stability of the endothelium. Even so, they can crosstalk16,20. 
In spite of all the adhesion molecules present in endothelial cells, only a few are 
endothelial specific: claudin-5 in tight junctions and vascular endothelial (VE)-cadherin 
and vascular endothelial-protein tyrosine phosphatase (VE-PTP) in adherent 
junctions20.  
Figure 1 – Schematic representation of endothelial cell adhesion. 
20 
 
The major component of adherent junctions is VE-cadherin, an endothelial 
specific and calcium-dependent glycoprotein, which is very dynamic and sensitive to 
extracellular stimuli. It may directly or indirectly stimulate signaling pathways in the 
cells18. VE-cadherin may form complexes with vascular endothelial growth factor 
receptor (VEGFR)2 and with transforming growth factor β receptor (TGFβR) I and II. 
Their ligands, VEGFA and TGFβ, respectively, trigger endothelial differentiation, growth 
and stabilization. In response to VEGFA, the VE-Cadherin-VEGFR2 complex activity 
prevents apoptosis and promotes cell stability through activation of Akt, while inhibits 
cell cycle mediated by p42/44 mitogen-activated protein kinase (MAPK). The VE-
cadherin-TGFβR complex also promotes vessel stabilization, inhibiting endothelial 
proliferation and migration in response to TGFβ20. 
Another important complex in stable vessels is Tie2-VE-PTP. Tie2 is a tyrosine 
kinase receptor that sustains cell quiescence and stabilization in response to its ligand, 
Angiopoietin1 (Ang1), which is produced by the pericytes. Besides Tie2, VE-PTP can 
also combine with VE-cadherin, although it is not known if these interactions are 
mutually exclusive or not20. 
 
2.2.2. Cell-to-matrix Junctions 
 
The ECM is fundamental for the endothelial barrier function and, in general, is 
composed by collagen, others glycoproteins and proteoglycans. It is the diversity and 
the amount of these components that portray different tissue-specific ECMs19. 
The endothelial cells are provided with integrins, which are bound to the ECM in 
restrict locals called “focal adhesions”. Each integrin is a heterodimer resulting from a 
unique combination of α- and β-subunits. These subunits are type I transmembranar 
glycoproteins with a small cytoplasmic domain and a large extracellular domain19. 
Integrins bind to the Arg-Gly-Asp (RGD) sequence of ECM proteins such as fibronectin, 
fibrinogen, vitronectin, and collagen. Their cytoplasmic domain interacts with actin-
binding proteins, such as vinculin, α-actinin, paxillin and talin. These interactions 
influence cell morphology and paracellular permeability19. 
In the migration process, integrins are recycled by caveolae, a special type of 
lipid raft invaginations that mediate integrin interactions with Rho GTPases. Thereby, 
integrins activate Rho GTPases, like RhoA, Rac1 and Cdc42, inducing membrane 
protrusion14. 
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2.3. Endothelial cells proliferation and apoptosis 
 
During vascular plexus remodeling and in response to angiogenic stimuli, 
endothelial cells proliferate, migrate and coalesce. Their proliferation must be tightly 
regulated to reach proper architecture, stability and function of an expanding vascular 
network. As endothelial cells become more specialized and the circulatory system is 
completely created, these cells decrease gradually their proliferation rate. Hence, 
mature endothelial cells have a low proliferative rate, except in angiogenesis, and a 
low apoptotic rate, except in disease1,14. 
The cell survival and proliferation is induced mainly by the phosphoinositide 3-
kinase (PI3K)/Akt signal transduction cascade. This signaling pathway is strongly 
regulated by phosphatase and tensin homolog (PTEN), a well-known tumor suppressor 
protein. PTEN suppresses Akt activity through the dephosphorylation of the 
phosphatidylinositol (3,4,5)-trisphosphate (PIP3), which is required to Akt activation. 
Akt, also known as protein kinase B, is a serine/threonine-specific protein kinase with a 
role in several cellular processes like translation initiation, cell growth, glycogen 
synthesis, cell cycle, proliferation and apoptosis21. 
In normal conditions, Akt phosphorylates p21 and p27 cyclin-dependent kinase 
(Cdk) inhibitors, leading to their cytosolic localization, promoting the cell cycle. In 
addition, Akt phosphorylates procaspase-9, decreasing its protease activity, and Bcl-2-
associated death promoter (BAD) protein, hence inhibiting apoptosis. However, when 
PTEN is overexpressed, the activity of Akt is inhibited, inducing apoptosis, suppressing 
cell cycle and promoting the increase of p53 levels, enhancing the transcription of 
several genes such as PTEN and p2121,22. 
 
3. Angiogenesis 
 
Angiogenesis is a highly regulated process for the forming vasculature to have 
the proper integrity and patterning. It may occur through endothelial sprouting or 
through non-sprouting intussusceptive microvascular growth (IMG)1,20. 
The endothelial sprouting (Figure 2) involves the loss of junction contacts 
between the endothelial cells, degradation of the basement membrane by proteases 
and migration of tip cells in reaction to angiogenic stimuli, such as VEGF, even if not all 
the exposed endothelial cells respond to the proangiogenic signals1,14,20. 
Notwithstanding, recent data go against the immutably of tip and stalk cells and 
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demonstrate that there is a dynamic arrangement of cells that change position 
frequently within a growing vascular sprout, through interchangeable adhesions 
between cells and the ECM14. 
The IMG (Figure 3) consists in the insertion of several transcapillary pillars by a 
process known as intussusception, increasing capillary network and complexity1,20. 
   
 
 
Figure 3 – Schematic representation of the intussusceptive microvascular growth. Adapted 
from De Spiegelaere W, Casteleyn C, Van den Broeck W, Plendl J, Bahramsoltani M et al. 
Intussusceptive angiogenesis: a biologically relevant form of angiogenesis. J Vasc Res. 2012; 
49(5): 390-404. (a) The opposite walls of the capillary start to migrate to each other, (b,c) a 
intraluminal pillar is formed and (d) the cell-to-cell junctions are established. (e) The further 
growth of this pillar forms two new vessels from the original one. 
Figure 2 – Schematic representation of sprouting angiogenesis. Adapted from De Spiegelaere 
W, Casteleyn C, Van den Broeck W, Plendl J, Bahramsoltani M et al. Intussusceptive 
angiogenesis: a biologically relevant form of angiogenesis. J Vasc Res. 2012; 49(5): 390-404. 
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Bone marrow vessels: “instructors” of hematopoietic 
function 
 
Several studies suggests that endothelial cells are not just a barrier between the 
vessel lumen and surrounding tissue that controls the traffic of cells and molecules, 
but also potential producers of stem cell and progenitor cells active angiocrine 
factors4. 
The angiocrine factors are paracrine released endothelial-derived factors. These 
may be growth factors, trophogens, adhesion molecules as intercellular adhesion 
molecule 1 (ICAM1), vascular cell adhesion molecule 1 (VCAM1), E-selectin, P-selectin 
and hyaluronan, and chemokines as interleukin (IL)-8, monocyte chemoattractant 
protein 1 (MCP-1) and stromal cell-derived factor 1 (SDF1). The angiocrine factors have 
a key role in tissue repair, enhanced after treatment with anti-angiogenic and 
chemotherapeutic agents or radiotherapy. By modulating the proliferation of stem and 
progenitor cells23, some of these particular factors, that might support hematopoiesis 
but not tumorigenesis, improve bone marrow recovery, mitigating the chemotherapy 
and irradiation effects4. 
It is thought that the vascular niche within each organ is scheduled to fill the 
physiological requirements of a certain tissue, suggesting an organ-specific regulation 
of the expression of angiogenic factors24. Endothelial cells might be therefore 
considered instructive organ-specific vascular niches, since that they control the 
maintenance and the reconstitution of stem and progenitor cells through secretion of 
specific angiocrine factors and deposition of ECM4. 
A recent study demonstrate that direct cellular interaction with endothelial cells 
control the fate of hematopoietic stem and progenitor cells (HSPCs) and that the 
equilibrium between proliferation of long-term hematopoietic stem cells (LT-HSCs) and 
lineage-specific differentiation of HSPCs is due to the differential recruitment of Akt 
and mitogen-activated protein kinase (MAPK) signaling pathways in endothelial cells. 
Both pathways act upregulating distinct angiocrine factors. Akt-activated endothelial 
cells induce the expression of HSPC-active angiocrine factors by the action of mTOR 
and favor the self-renewal of LT-HSCs and the proliferation of HSPCs. On the other 
hand, MAPK co-activation promotes maintenance and lineage-specific differentiation 
of HSPCs. These both processes are fundamental during hematopoiesis recovery to 
ensure not only the differentiation of the HSPCs, but also the LT-HSC self-renewal24. 
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Another recent study shows that liver sinusoidal endothelial cells (LSECs) initiate 
and support liver regeneration after a 70% partial hepatectomy. It had been further 
proved that VEGF-A receptor-2 (VEGFR2) and the subsequent endothelial cell-specific 
transcription factor Id1 are crucial for the proliferation and recovery of the hepato-
vascular mass due to lack of LSEC-derived angiocrine factors, such as hepatocyte 
growth factor (HGF)25. It is likewise described that pulmonary capillary endothelial cells 
(PCECs) proliferate after unilateral pneumonectomy (PNX), favoring alveologenesis 
through the intermediary of VEGFR2 and fibroblast growth factor receptor 1 (FGFR1) 
and subsequent matrix metalloproteinase 14 (MMP14)26. 
Thereby, vascular derived-tumor specific angiocrine factors may be huge 
potential therapeutic targets fighting against cancer, since this is a targeted strategy 
that reduces therapy-induced vascular toxicity4. 
However, even though the evidences of the production of stem cell active factors 
such as bone morphogenetic protein 2 (BMP2), BMP4, tumor growth factor β (TGFβ), 
brain-derived neurotrophic factor (BDNF), jagged 1 and jagged 2 and angiogenic 
factors such as placental growth factor (PGF), angiopoietin2 (Ang2), VEGFA, fibroblast 
growth factor 2 (FGF2) and platelet-derived growth factor (PDGF) by endothelial cells 
that sustain organogenesis, tissue recovery and even tumorigenesis, the exact identity 
of the organ-specific angiocrine factors is not known yet4. 
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MicroRNAs 
 
MicroRNAs (miRNAs) are an abundant class of endogenous, short (20 to 25 
nucleotides in length), highly conserved, non-coding ribonucleic acid molecules. They 
have a tissue- and cell-type-specific pattern and are important regulators of gene 
expression at post-transcriptional level that have been shown to control a wide range 
of biological functions such as cellular proliferation, differentiation, metabolism and 
apoptosis5,27. 
 
1. miRNA biogenesis and mechanism of action 
 
miRNAs are transcribed from an individual miRNA gene, from an intron of a 
coding or non-coding gene or even from polycistronic transcripts. Additionally, this 
particular class of endogenous small RNA molecules may have their own promoters, 
being expressed in an independent way or, if organized in clusters, they share the 
same transcriptional regulation5,27. 
As shown in Figure 4, the long primary transcript generate a stem-loop 
conformation, called primary miRNA (pri-miRNA), which is processed by Drosha, a 
ribonuclease III (RNase III), together with DGCR8, a molecular anchor necessary for the 
recognition of pri-miRNA. An alternative pathway may occur to bypass the cleavage 
step from Drosha, if the miRNA derives from intronic hairpins, being called mirton. In 
this case, spliceosome acts like Drosha processing pri-miRNA. After this nuclear 
processing into stem-loop precursor (pre-miRNA), this is subsequently transported to 
the cytoplasm by Exportin-5 in a Ran-GTP-dependent manner. Once in the cytoplasm, 
Dicer, another RNase III, cleaves the pre-miRNA to produce the mature ≈22 nucleotide 
miRNA duplex, which is incorporated as single-stranded RNAs into the effector RNA-
induced silencing complex (RISC). The miRNA duplex is unwound into the mature guide 
strand and its complementary passenger strand, which is mostly degraded. The 
process by which the cell selects one strand of the double strand miRNA is really 
unknown. Included in RISC, whose key components belong to Argonaute (Ago) family, 
guide strand miRNA conducts the complex to its target RNA. The mature miRNA binds 
to the target mRNA coding sequences or to the 5’ or 3’-untranslated regions (UTR) by 
Watson-Crick base pairing with the help of RISC. However, most of the predicted and 
experimentally characterized miRNA sites are positioned in the mRNA 3’UTR. This 
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interaction leads to translational repression in cases of low miRNA-target 
complementarity or to mRNA degradation whether this interaction is perfect or near-
perfect. It is noted that various miRNAs may cooperatively bind to the same 3’UTR and 
that each miRNA may regulate multiple targets5,6,27,28. Cells may further exchange 
miRNAs between them via exosomes, producing biological effects close by or at a 
distance29. In addition, it is suggested that miRNAs may also participate in the 
regulation of transcription or splicing of transcripts within the nucleus5,6,27,28. 
 
 
The deregulation of a single miRNA affects the expression of many different 
proteins and other miRNAs and may lead to several diseases such as vascular diseases 
and cancer30. 
 
2. miRNA nomenclature 
 
With the exception of let family of miRNAs, because this was the first family to 
be discovered, miRNAs are uniformly named using a three-letter abbreviation of the 
specie they belong to (e.g. hsa is the abbreviation for Homo sapiens as mmu is the 
abbreviation for Mus musculus). This prefix is separated by a hyphen from the word 
Figure 4 – Schematic representation of the miRNA biosynthesis. Adapted from Breving K, Esquela-
Kerscher A. The complexities of microRNA regulation: mirandering around the rules. Int J Biochem Cell 
Biol 2010; 42(8): 1316-1329. 
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“miR”, which is also separated by a hyphen from the corresponding number or number 
and letter of the miRNA (e.g. hsa-miR-21)31. 
To distinguish both strands of the miRNA duplex, there are two different naming 
conventions. Accordingly to the relative abundance of the miRNA in the cell, the less 
abundant form name is followed by a star (e.g. hsa-miR-21*), in opposition to the most 
abundant one.  However, since the relative abundance is not always well known, 
currently there’s a new miRNA labeling depending on the relative position of the 
mature sequence, considering the pre-miRNA as a reference. In this way, the miRNA 
with origin in the 5’ end of the pre-miRNA gains the suffix “5p” (e.g. hsa-miR-21-5p), 
whereas the one derived from the 3’ end gets the suffix “3p” (e.g. hsa-miR-21-3p). 
Both classifications are not related once relative abundance of a miRNA is not related 
to its relative origin position in the precursor31. 
 
3. Prediction of miRNA putative targets 
 
Unlike plant microRNAs, wherein the complementarity with their targets must be 
nearly perfect both in coding sequences as in untranslated regions (UTR)32, most 
animal microRNAs are more tolerant to imperfect pairing, like G:U pairing, bulged 
nucleotides and/or mismatches between microRNA and its target33. Besides, while 
plant microRNA targets have only a single binding site, the animal ones have multiple 
binding sites34. 
For microRNA to bind the target mRNA, it must contain mandatorily a 5’-end 
seed sequence, the 5’-end segment of the microRNA with 6-8 nucleotides in length, 
conserved and often flanked by adenosines. Moreover, if there is insufficient base-
pairing of this seed, 3’-end of microRNA might support it. The free energy of 
microRNA:mRNA duplex (ΔG), which is the required energy for the formation of the 
duplex,  and the site accessibility (ΔΔG), which balances the required energy to unfold 
and to refold of the duplex, are also important for the microRNA:mRNA binding. 
Besides, the existence of multiple binding sites within a gene for a single microRNA or 
for different microRNAs allows a dose-dependent and synergistic effect on target 
expression. Likewise, the sequences around the microRNA binding site like an 
enrichment of adenosines and uracils, called ALU sequences, may affect the 
accessibility35. 
Therefore, to predict animal microRNA targets, a computer algorithm is created 
after the training-set for common distinctive properties like structural and sequence 
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features of a subset of known microRNAs. This algorithm scores sequences on their 
similarity to these properties and consequently on their probability to be valid. It is the 
different weighting and combination of multiple properties that give rise to several 
algorithms to a more required accuracy32. 
Currently, there are several algorithms that predict microRNA targets, being 
PicTar, miRanda, TargetScan and TargetScanT the most used ones. However, miRanda 
and PITA are considered the more accurate databases. To obtain more robust and 
confident target predictions, there are target prediction portals like miRecords, 
miRWalk and mirDIP (microRNA Data Integration Portal), which compile several 
algorithms (Figure 5)32. 
miRecords is a very complete portal allowing the combination of till 11 
algorithms (DIANA-microT, MicroInspector, miRanda, miRDB, miRTarget2, miTarget, 
NBmiRTar, PicTar, PITA, RNA22, RNAhybrid and TargetScan) and it permits the 
restriction to present the prediction of at least a desired number of databases, not 
selecting them neither putting bias36. 
miRWalk provides information of microRNA-target interactions from human, 
mouse and rat by 8 programs (RNA22, miRanda,  miRDB, TargetScan,  RNAhybrid,  
PITA,  PICTAR and Diana-microT) and it is applied not only to the 3’UTR, but to the 
whole sequence (promoter, 5’UTR, CDS, 3’UTR). This portal allows the selection of the 
desired prediction programs37. 
Figure 5 - Schematic representation of miRNA multiple target prediction portals. 
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mirDIP is an up-to-date portal that also integrates several prediction algorithms. 
Each algorithm takes into account the characteristics of microRNA:mRNA target 
interaction in different proportions, allowing the researcher to manage combinations 
of databases and database characteristics options35. 
 
 
MicroRNA-21 
 
In Homo sapiens, miR-21 is mapped on chromosome 17q23.2 in an intronic 
region within a gene, TMEM49, which encodes a human transmembrane protein 
involved in cell-to-cell adhesion, homolog of rat vacuole membrane protein (VMP1). In 
mouse, it is expressed in chromosome 11. Despite this, miR-21 has its own promoter 
regions, being independently regulated8,38. 
This miRNA belongs to the typical miRNA signature of the vasculature and is 
selectively regulated by several conserved enhancer molecules such as the activation 
protein 1 (AP-1) that is composed of Fos and Jun family nuclear oncogenes, Ets/PU.1, 
CCAAT enhancer binding protein α (C/EBP-α), nuclear factor I (NFI), serum response 
factor (SRF), p53 and signal transducer and activator of transcription 3 (STAT3)6,38. 
MiR-21 and NFIB have a double-negative feedback, which supports miR-21 expression. 
Besides, some tumor suppressor elements like forkhead box O3 (Foxo3a) and 
BMP-6 may negatively regulate miR-21, while tumor growth factor β (TGFβ) appears to 
upregulate its expression8,39,40. 
This miRNA has likewise numerous targets41. However, very few pathways are 
known to be triggered by miR-21. However, it is consensual that its overexpression 
suppresses PTEN expression, which leads to an increase in hypoxia inducible factor 
(HIF)-1α and VEGF levels (not HIF-1β because it is constitutively active) through AKT 
and extracellular signal-regulated kinase (ERK)1/2 pathway and consequently 
promotes angiogenesis7. 
MiR-21 is then described to act as a tumor promoter, a genuine oncomiR, in 
almost every classes of human cancers41. This includes breast cancer, glioma, 
retinoblastoma, colangiocarcinoma, colorectal cancer, renal carcinoma, hepatocellular 
carcinoma, non-small cell lung cancer (NSCLC) and hematological malignancies such as 
chronic lymphatic leukemia, acute myeloid leukemia, B-cell lymphoma and Hodgkin’s 
lymphoma8,42,43,44,45. 
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Most of tumors with miR-21 upregulated have STAT3 constitutively and 
inappropriately activated. For instance, in Sézary Syndrome, a rare leukemic cutaneous 
T-cell lymphoma (CTCL), STAT3 is upregulated through IL-21 stimulation of CD4+ T 
cells. As a result, STAT3 is constitutively active in these cells and directly targets miR-
21. So, expression of miR-21 is increased in neoplastic CD4+ cells from Sézary 
patients38. However, STAT3 seems to have a paradoxical role as its activation through 
interferon β (IFNβ) regulates miR-21 expression in a negative way. This paradox may 
be explained by the context, different stimuli and cell types8. 
Besides being expressed in neoplastic and hypoxic conditions, under normal 
physiological conditions, miR-21 is usually expressed in post-mitotic basal and 
suprabasal layers of the epidermis46 as well as in hair follicle epithelium in mouse skin, 
but it was not seen in the dermis47. Its expression might also be found in the liver, 
being upregulated during the proliferative phase of liver regeneration48 and in the 
placenta49. In addition, miR-21 is highly induced by luteinizing hormone (LH) in murine 
granulosa cells50. Furthermore, it is transiently upregulated during the differentiation 
of the human adipose-derived stem cells (hASCs), modulating TGFβR2 expression, 
which suggests that miR-21 controls adipocyte differentiation51. MiR-21 is also present 
in the heart of mice52, being in high levels in cardiac fibroblasts53. However, normal 
brain seems to have low levels of it53. It is expressed in mouse motor neuron MN-1 
cells as well55,56. 
The physiological high expression levels of miR-21 in primary bone marrow–
derived monocyte/macrophage precursors (BMMs) are mandatory for 
osteoclastogenesis, process stimulated by the receptor activator of nuclear factor κB 
ligand (RANKL). These high levels of miR-21 may also be required for myeloid 
differentiation. Nevertheless, although it is described that miR-21 is promonopoietic, 
given that it increases monocytic cell number57, the role of miR-21 in normal 
myelopoiesis remains to be clarifyed58.  In the bone marrow, it is only known that miR-
21 is one of the most abundant miRNA expressed in all T cell subsets, being involved in 
in vivo differentiation of human CD8+ T lymphocytes59. Even so, its function in the 
bone marrow microenvironment, and in particular in the bone marrow endothelial 
cells is still unknown. 
Given the lack of information on the function of miR-21 in angiogenesis or in 
angiocrine factors function, it is legitimate to speculate that miR-21 may potentially be 
exploited for therapeutic purposes such as for the treatment of bone metabolic 
disorders with excessive osteoclast development and activity, such as osteoporosis, 
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and for the treatment of proliferative vascular diseases, such as atherosclerosis and 
stroke. MiR-21 targeting therapy has great clinical usage potential independent of 
PTEN status44. 
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Aims 
 
In this project, it was proposed to evaluate the role of miR-21 in the bone 
marrow microenvironment, focusing on bone marrow endothelial cells. 
 
For that purpose, the aims of this work are: 
1. Evaluate miR-21 expression on bone marrow cells; 
2. Identify predicted targets underlying miR-21 regulation of angiogenesis; 
3. Assess endothelial cell phenotypic changes modulated by miR-21 levels; 
4. Mice genotyping for further in vivo assays on the miR-21 function. 
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Methods 
 
 
Cell Culture 
 
Human umbilical vein endothelial cells (HUVECs) were used for transfection 
experiments in the fourth passage. Cells were cultured in endothelial cell basal 
medium-2 (EBM-2), from Lonza, supplemented with hydrocortisone, human fibroblast 
growth factor (hFGF), VEGF, a recombinant analog of human insulin-like growth factor-
1 (R3-IGF-1), ascorbic acid, human epidermal growth factor (hEGF), heparin, 
gentamicin, amphotericin and containing 10% fetal bovine serum (FBS) in a flask 
coated with 0,2% gelatin. They were incubated at 37ºC with 5-10% CO2 supplied and 
100% relative humidity, free of contamination. 
 
 
HUVECs Transfection  
 
HUVECs transfection was done using an Ambion® Anti-miR™ miRNA inhibitor 
(anti-miR-21) or an Ambion® Pre-miR™ miRNA precursor (pre-miR-21) or an Ambion® 
negative control, the scramble (Sc), all in a final concentration of 5 μM. Anti-miRs® are 
single-stranded, synthetic miRNA inhibitors which bind specifically and inhibit the 
activity of endogenous miRNA. Pre-miRs®, on the other hand, are double-stranded 
molecules whose function in cell is similar to that of endogenous miRNAs. Scramble 
has the same nucleotide composition, but not the same sequence and serves as a 
negative control of transfection, which distinguishes sequence-specific silencing from 
non-specific effects. Triplicates were performed for each condition. 
Electroporation cuvettes (BioRad®) were sterilized through ultraviolet radiation 
in a laminar air flow chamber for at least 15 minutes. In addition, 6-well plate, 
previously covered with 0,2% gelatin, was prepared with EBM-2 with 10% FBS, 
supplements, but without antibiotics. 
HUVECs, maintained in log phase growth at 50-80% confluency, were washed 
twice with Dulbecco’s phosphate-buffered saline (DPBS®), from Invitrogen, to remove 
cellular waste. After that, an incubation with a solution of trypsin 1x at 37ºC for around 
2 minutes detached cells from the flask surface. Cells were then homogenized in 
Dulbecco's modified eagle medium (DMEM®), from Invitrogen, with 10% FBS, which 
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inhibits the action of trypsin, and were counted on a Neubauer improved 
hemocytometer. 3x105 cells/well were collected and centrifuged at 1200 rpm during 5 
minutes. Discarded the supernatant, the pellet was resuspended in 500μl/well of Opti-
MEM® (Invitrogen) without FBS and without antibiotics, whereof 500 μl were 
distributed to each cuvette.  Then, 5 μM of the modulator were added to each 
condition and each mix was finally electroporated by the Gene Pulser XcellTM 
Electroporation System, with 1 pulse of 220 Volts (V), with a capacitance of 500 
microfaradays (μF) and a cuvette gap of 4 milimeters (mm). Transfected HUVECs were 
immediately transferred to the respective well in the previously prepared plate and 
were incubated at 37ºC with 5% CO2 for 48 hours for the transfection to take place. 
 
 
RNA Extraction 
 
High-quality total RNA was purified through TRIzol® method, also known as 
guanidine isothiocyanate method. TRIzol® Reagent (Sigma-Aldrich) is a monophasic 
solution of phenol and guanidine isothiocyanate which lyses cells and prevents the 
activity of RNase enzymes, by denaturing them. 
After homogenization of the samples with this reagent, chilled chloroform 
(200μl/ml TRIzol® Reagent) was added. Samples were homogenized once again and 
centrifuged at 14000 rpm during 20 minutes at 4ºC for the phase separation to occur. 
At this point, 3 phases are visible: a red organic phase, which contains protein, a white 
interphase containing DNA and a colorless upper aqueous, where RNA remains 
exclusively. Afterward, for the RNA precipitation, this upper aqueous phase was 
carefully transferred into a fresh tube, mixed with chilled isopropanol (500μl/ml 
TRIzol® Reagent) and kept O/N at -20ºC. A new centrifugation at 14000 rpm during 20 
minutes at 4ºC formed a pellet on the side and bottom of the tube. Supernatant was 
discarded and RNA pellet was washed twice with chilled 80% ethanol in 
diethylpyrocarbonate (DEPC)-treated water (1ml/ml TRIzol® Reagent), through 
vortexing followed by centrifugation at 14000 rpm during 20 minutes at 4ºC. Finally, 
briefly dried RNA pellet was resuspended in DEPC-treated water and RNA 
concentration was measured on a NanoDrop® 1000 Spectrophotometer (Thermo 
Fisher Scientific), which measures 1 μl samples with high accuracy. RNA was always 
stored at -80ºC. 
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cDNA Synthesis 
 
1. cDNA Synthesis for analysis of miRNA levels 
 
cDNA for analysis of miRNA levels was synthesized from 500 ng of total RNA 
using the NCodeTM miRNA First-Strand cDNA Synthesis Kit (Invitrogen). This method 
provides the polyadenylation of mature miRNAs from total RNA and synthesis of cDNA 
from the tailed miRNAs for use in real-time quantitative polymerase chain reaction 
(RT-qPCR). 
First, 10 mM ATP was diluted in 1 mM Tris (pH 8.0) in a 1:4 proportion. The 
addition of poly(A) tails to the total RNA was achieved through the incubation of 500 
ng/μl of total RNA with the master mix 1, during 15 minutes at 37ºC in a thermal 
cycler. 
 
Master mix 1 1X 
5X miRNA Reaction Buffer 5 μl 
25 mM MnCl2 2,5 μl 
10 mM ATP (diluted 1:4) 1 μl 
Poly A Polymerase  0,5 μl 
DEPC-treated water Up to the final volume (23 μl) 
 
After that, 6 μl of the polyadenylated template was taken to continue the cDNA 
synthesis, while the remaining was stored at -80ºC. Master mix 2 was added to the 6 μl 
polyadenylated RNA, incubated at 65ºC during 5 minutes and placed 1 minute on ice. 
Then, polyadenylated RNA was reverse transcribed through the addition of master mix 
3 and incubation at 50 ºC for 50 minutes followed by 85 ºC for an additional 5 minutes, 
in order to stop the reaction. cDNA samples were stored at -20ºC. 
 
Master mix 2 1X 
Annealing Buffer 1 μl 
Universal RT Primer (25 μl) 3 μl 
 
Master mix 3 1X 
2X First-Strand Reaction Mix 10 μl 
SuperScript® III RT/ RNaseOUT® Enzyme Mix 2 μl 
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2. cDNA Synthesis for analysis of expression of coding genes 
 
To analyze the expression of coding genes, cDNA was synthesized from 500 ng of 
total RNA, to which was added the master mix 1. It was incubated 5 minutes at 65ºC 
and then added the master mix 2, previously incubated 2 minutes at 25ºC. 
 
Master mix 1 1X 
2,5 μM dNTPs 1 μl 
Random Primers 1 μl 
 
Master mix 2 1X 
5X First Strand Buffer 4 μl 
0,1 M DTT 2 μl 
RNase-OUT 1 μl 
 
Finally, 1 μl of SuperScript® II RT enzyme was added to each tube, followed by 
incubations of 10 minutes at 25ºC, 50 minutes at 42ºC and 15 minutes at 70ºC. cDNA 
products were diluted in DEPC-treated water, in the proportion of 1:2, and stored at -
20ºC. 
 
 
Real-time Quantitative PCR (RT-qPCR) 
 
The amplification and relative quantification of coding and non-coding genes 
(miRNAs) was performed in a ViiA™ 7 Real-Time PCR System (Applied Biosystems®) 
instrument in 384-well plates. Relative quantification was carried out through the 
comparative threshold cycle (Ct) method (∆∆Ct). 
The run method was started with the hold stage (2 minutes at 50ºC and 10 
minutes at 95ºC), then 40 cycles of 15 seconds at 95ºC and 1 minute at 60ºC were 
used for the PCR stage, and finally the melt curve stage with 15 seconds at 95ºC and 1 
minute at 60ºC. 
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1. Quantification of miRNA levels 
 
To perform RT-qPCR for the analysis of miRNA levels, the Power SYBR® Green 
PCR Master Mix and the Universal qPCR Primer (Applied Biosystems®) were used. The 
other primer used in the reaction was the sequence of the miRNA to be analyzed. In 
the case of hsa-miR-21-5p, it was: 5’-TAGCTTATCAGACTGATGTTGA-3’. However, 
human U6 and 18S, the housekeeping genes used for the normalization, have their 
own specific forward and reverse primers. 
 
Primer Sequence 5’ - 3’ 
U6 Forward GTGCCGCTTCGGCAGCACATATAC 
U6 Reverse AAAAATATGGAACGCTTCACGAATTTG 
18S Forward GCCCTATCAACTTTCGATGGTAGT 
18S Reverse CCGGAATCGAACCCTGATT 
 
The following master mix were distributed per well of the 384-well plate with 2 
μl of cDNA. The plate was carefully sealed and centrifuged at 1400 rpm during 2 
minutes at 4ºC. 
 
Master mix 1X 
Bidistilled water 2,6 μl 
SYBR® Green PCR Master Mix 3,5 μl 
2% Bovine serum albumin (BSA) 0,075 μl 
10 μM UniPrimer qPCR 0,15 μl 
10 μM hsa-miR-21-5p Primer 0,15 μl 
 
 
2. Quantification of coding genes 
 
Also to perform the RT-qPCR for analysis of the expression of coding genes, 
Power SYBR® Green PCR Master Mix was used. Though, each gene has its own specific 
forward and reverse primers and only human 18S was used as housekeeping gene. 
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Primer Sequence 5’ - 3’ 
18S Forward GCCCTATCAACTTTCGATGGTAGT 
18S Reverse CCGGAATCGAACCCTGATT 
Jagged1 Forward CGGCTTTGCCATGTGCTT 
Jagged1 Reverse TCTTCCTCCATCCCTCTGTCA 
PTEN Forward TGTTGTTTCACAAGATGATGTTTGA 
PTEN Reverse CAGACCACAAACTGAGGATTG 
RhoB Forward ATGTGCTTCTCGGTGGACAG 
RhoB Reverse GATGGGCACATTGGGACAGA 
RECK Forward CAGGTCTGCCTGACGACTTT 
RECK Reverse GCTCCATGTGGTCTGTGTCA 
Annexin A1 Forward AACAGGAAAGCCCCTGGATG 
Annexin A1 Reverse TGGCAGCACGAAGTTCATCA 
IL-15 Forward ACAGAAGCCAACTGGGTGAA 
IL-15 Reverse TGCAACTGGGGTGAACATCA 
Spry1 Forward GGAAATCCACGGTGATCCT 
Spry1 Reverse GGCATGCATCTGAAATCCTT 
Spry2 Forward TCAGAGCCATCCGAAACACC 
Spry2 Reverse TCGTGTTTGTGCTGAGTGGA 
TSP-1 Forward TGGAGCGGAAAGACCACTCT 
TSP-1 Reverse CCGCCTTGCCATTGGA 
 
The following master mix were distributed per well of the 384-well plate with 2 
μl of cDNA. The plate was carefully sealed and centrifuged at 1400 rpm during 2 
minutes at 4ºC. 
 
Master mix 1X 
Bidistilled water 2 μl 
SYBR® Green PCR Master Mix 4 μl 
10 μM UniPrimer qPCR 0,15 μl 
10 μM hsa-miR-21-5p Primer 0,15 μl 
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Matrigel Assay 
 
BD Matrigel™ Basement Membrane Matrix Growth Factor Reduced was used to 
perform tube formation assay. It is composed by a mixture of basement membrane 
components, which stimulates endothelial cells to attach and differentiate. 
To each well of a 24-well plate was added 5 unid/ml heparin to be dissolved with 
200 ml of BD Matrigel™ Basement Membrane Matrix Growth Factor Reduced. In 
addition, 50 ng/ml VEGF and 5 ng/ml bFGF were added to the respective condition, to 
be tested individually.  Then 3x105 transfected HUVECs were added to each well and 
24 hours later, tube formation was measured counting the number of tubules formed.  
 
 
“Wound healing/Scratch” Assay 
 
After the transfection of cells in a 0,2% gelatin coated plate, cells were left to 
grow until confluence was achieved. With the help of a 10 μl tip, a simple scratch of 
the cell monolayer was carefully performed not to detach gelatin. Pictures were taken 
at the time points 0, 6, 12 and 24 hours and migration was evaluated through the 
measurement of the size of the “wound”, a measure of the rate of cell migration in 
response to the different experimental conditions. 
 
 
Mice Genotyping 
 
Mice were genotyped by PCR. Each mouse was labeled and 0,5 cm of the tail was 
cut into an Eppendorf tube. This tail tip was then digested in 300 μl Laird’s buffer and 3 
μl proteinase k at 55ºC O/N with shaking. After spinning down the hairs and bones, 
supernatant was collected to a fresh tube and DNA was precipitated with 300 μl 
isopropanol, by just inverting the tube. DNA was then fished into 200 μl bidistilled 
water and dissolved at 37ºC with shaking for 1 hour. 2 μl of this DNA solution was used 
to perform the followed PCR reactions. 
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Master mix for VE-Cadh-Cre-ERT2 1X 
10X PCR buffer 2,5 μl 
10 mM dNTPs 0,5 μl 
40 mM MgCl2 2 μl 
10 μM Cre 313U 0,7 μl 
10 μM Cre 6831 0,7 μl 
Bidistilled water 16,3 μl 
Taq polymerase 0,3 μl 
 
Master mix for miR-21lox 1X 
10X PCR buffer 2,5 μl 
10 mM dNTPs 0,5 μl 
40 mM MgCl2 2 μl 
10 μM miR-21 conditional Fwd 0,7 μl 
10 μM miR-21 conditional Rev 0,7 μl 
Bidistilled water 16,3 μl 
Taq polymerase 0,3 μl 
 
Master mix for Dll4lox 1X 
10X PCR buffer 2,5 μl 
10 mM dNTPs 0,5 μl 
40 mM MgCl2 1 μl 
10 μM Dll4 lox 5’ 0,7 μl 
10 μM Dll4 lox 3’ 0,7 μl 
Bidistilled water 17,3 μl 
Taq polymerase 0,3 μl 
 
These reactions took place in the thermal cycle with the following PCR program: 
1 cycle at 95ºC during 3 minutes, 35 cycles of 30 seconds at 95ºC, 30 seconds at 60ºC 
and 35 seconds at 72ºC, and a final cycle at 72ºC during 3 minutes. 
The primer sequences used are listed above. 
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Primer Sequence 5’ – 3’ 
Cre 313U CCAGCTAAACATGCTTCATC 
Cre 6831 CGCTCGACCAGTTTAGTTAC 
miR-21 conditional 5’ GCTTACTTCTCTCTGTGATTTCTGTG 
miR-21 conditional 3’ GGTGGTACAGCCATGCGATGTCACGAC 
Dll4 lox 5’ GTGCTGGGACTGTAGCCACT 
Dll4 lox 3’ TGTTAGGGATGTCGCTCTCC 
 
Solutions: 
 
Laird’s buffer  Lysis buffer 
1 M Tris-HCl pH 8,5  50 ml  3 M KCl 834 μl 
0,5 mM EDTA 5 ml  1 M Tris-HCl pH 8,3 500 μl 
20% SDS 5 ml  1 M MgCl2 100 μl 
5 mM NaCl 20 ml  10% Tween 20 2,25 ml 
Ultrapure water Till 500 ml  10% NP40 2,25 ml 
   Ultrapure water Till 50 ml 
 
After amplification, DNA samples were run in a 2% (w/v) agarose gel in tris-
borate-EDTA (TBE) 0,5X. For DNA to be visible under UV light, 2,5% GelSafe or 4% 
Ethidium Bromide (EtBr) were added to the gel. Electrophoresis was carried out with 5 
μl molecular weight marker 50 bp ladder (Invitrogen) as a ruler and bands were seen 
through a UV transilluminator. 
 
 
Statistical Analysis 
 
Statistical significant differences were defined as p<0,05 and were calculated by 
unpaired two-tailed Student’s t test. Data were expressed as mean ± standard 
deviation of the mean. Statistical analysis and graphs were achieved using GraphPad® 
Prism 5.0 software. 
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Results and Discussion 
 
 
miR-21 expression on bone marrow cells 
 
In order to evaluate the levels of expression of miR-21 in hematopoietic stem 
cells (HSCs), endothelial cells (Lin- VE-Cadh+) and other hematopoietic (committed) 
cells (Lin+) isolated from mouse bone marrow, a RT-qPCR was performed. The Lineage 
Antibody Cocktail (Lin), as the name suggests, is a cocktail of antibodies that recognize 
mature cells markers. Therefore, lineage-negative (Lin-) cells are not committed yet. 
VE-Cadherin (VE-Cadh) is an endothelial specific marker, hence only VE-Cadh+ cells are 
considered endothelial. 
As observed in Figure 6, committed cells in general (Lin+) and endothelial cells 
(Lin- VE-Cadh+) express significantly more miR-21 than HSCs. 
 
 
 
Figure 6 - miR-21 expression in bone marrow subpopulations measured by RT-qPCR. Error 
bars represent standard deviation (SD). 
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hsa-miR-21-5p predicted targets 
 
The identification of miRNA predicted targets transcripts is reached through 
experiments, through the matching of sequences and through sites-specific 
mutagenesis or other techniques. 
In order to investigate the downstream targets underlying miR-21 regulation of 
angiogenesis, a bioinformatic approach was used besides the literature. 
A research in the European Bioinformatics Institute site 
(http://www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5/) with the gene 
EnsEMBL identifier (http://www.ensembl.org/index.html) was very useful in the 
selection of the possible miR-21 predicted target genes. This approach gets the miRNA 
sequences from the miRBase Sequence Database (http://www.mirbase.org/) and the 
majority of the genomic sequences from the EnsEMBL and applies the miRanda 
algorithm. It uses a dynamic programming alignment to identify highly complementary 
sites which are scored between 0 and 100, where 0 represents no complementarity 
and 100 complete complementary. It also takes advantage of the Vienna RNA folding 
package to predict and compare RNA secondary structures, assessing the energy, 
which is a measure for the thermodynamic stability of the double-stranded anti-
parallel duplex. 
This evaluation was carried out for angiocrine and angiogenic factors predicted 
to be miR-21 targets. 
 
 
1. Angiocrine factors  
 
Butler JM et al. have observed that the endothelium may act as a tissue capable 
of releasing growth factors and/or cytokines, which may act in a paracrine manner on 
neighboring cells. These factors have been referred as angiocrine factors and may 
comprise secreted factors as well as membrane-bound molecules or membrane 
proteins that can give rise to secreted variants21. 
Between all these angiocrine factors (Table 1), only Jagged1 (Jag1) is predicted to 
match with miR-21 (Table 2). 
Jag1 is a key Notch ligand that is important for a variety of cell fate decisions and 
many cellular biological processes, like the vascularization. It is a potent proangiogenic 
regulator60. Jag1 is expressed in many tissues, predominantly on the surface of 
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vascular endothelial cells, acting on Notch receptor in the neighboring vascular smooth 
muscle cells, following the “canonical” Notch pathway and thus promoting its 
differentiation and maturation through cell-cell interaction or trans-interaction61. In 
contrast, the same interaction within the same cell (cis-interaction) is thought to 
inhibit Notch signaling. This angiocrine factor is also involved in the formation of adult 
hematopoietic stem cells from the aorta61. 
 
Table 2 - Alignment of the Jag1 3’UTR with the miR-21 sequence, through MicroCosm 
Targets.  It provides the Ensembl gene accession, binding score, miRNA binding site, nucleotide 
starting and end of the mRNA binding site. 
Gene Name JAG1 
Transcript ENST00000254958  
Gene ENSG00000101384  
Description Jagged-1 precursor (Jagged1) (hJ1) (CD339 antigen). [Source:Uniprot/SWISSPROT;Acc:P78504] 
Hit 
infomation 
 
Rfam 
ID 
Score Energy Base P Poisson P Org P Start End Alignment 
hsa-
miR-
21 
15.7297 -12.23 
5.121250e-
02 
4.992320e-
02 
4.221070e-
05 
1220 1241 
AGUUGUAGUCAGACUAUUCGAU 
| :: | :| ||| |||||||| 
TAGGGAGTATTCTAATAAGCTA 
 
Table 1 – Angiocrine factors: function and organ specificity. Adapted from Butler JM, 
Kobayashi H, Rafii S. Instructive role of the vascular niche in promoting tumour growth and 
tissue repair by angiocrine factors. Nat Rev Cancer 2010; 10(2): 138-146. 
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The 3’UTR of Jag1 is a functional target of miR-21, which triggers its translational 
suppression62,63. The importance of this interaction is confirmed by Selcuklu SD et al. 
2012, whose results indicate that 17beta-estradiol (E2) enhances Jag1 expression, in 
ER+ breast cancer cells, by reducing the levels of miR-2163. 
 
 
2. Angiogenic factors 
 
The angiogenic factors are molecules that stimulate the growth of new blood 
vessels by modulating endothelial cell properties including proliferation, survival, 
migration, invasion, among others. Annexin A1 (ANXA1) (Table 3), interleukin (IL)-15 
(Table 4), PTEN, reversion-inducing cysteine-rich protein with Kazal motifs (RECK), Ras 
homolog gene family, member B (RhoB), Sprouty1 (Spry1) (Table 5Table 5), Sprouty2 
(Spry2) (Table 6) and thrombospondin1 (TSP-1) (Table 7) are predicted to be targets of 
miR-21 either by bioinformatic tools and/or by literature. 
  
2.1. ANXA1 
 
Annexin A1 (ANXA1) is a calcium-dependent phospholipid binding protein that is 
found in several tissues like lung, bone marrow and intestine. It is involved in many 
biological processes such as anti-inflammatory signalling, maintenance of cytoskeleton 
and ECM integrity, tissue growth, apoptosis and differentiation64. The activation of the 
p38/MAPKAP kinase-2/LIMK1/ANXA1 signaling axis is shown to be implicated in the 
endothelial cell migration, induced in response to vascular endothelial growth factor 
(VEGF)65. Therefore, ANXA1 is a regulator of this angiogenic effect. 
Even though there’s no evidence of it in the literature, in silico analysis reveals 
that ANXA1 contains a miR-21 binding site, which is complementary to the miR-21 
seed sequence in the 3’ untranslated region (3’-UTR). 
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Table 3 - Alignment of the ANXA1 3’UTR with the miR-21 sequence, through MicroCosm 
Targets.  It provides the Ensembl gene accession, binding score, miRNA binding site, nucleotide 
starting and end of the mRNA binding site. 
Gene Name ANXA1 
Transcript ENST00000257497  
Gene ENSG00000135046  
Description 
Annexin A1 (Annexin I) (Lipocortin I) (Calpactin II) (Chromobindin-9) (p35) (Phospholipase A2 inhibitory 
protein). [Source:Uniprot/SWISSPROT;Acc:P04083] 
Hit 
infomation 
 
Rfam 
ID 
Score Energy Base P Poisson P Org P Start End Alignment 
hsa-
miR-
21 
17.0555 -10.99 
1.335060e-
02 
1.326190e-
02 
3.487830e-
03 
47 67 
aGUUGUAGUCAGACUAUUCGAu 
 :| : ||| ||  ||||||| 
aTATTTTCA-TCCTATAAGCTt 
 
2.2. IL-15 
 
Interleukin (IL)-15 is expressed mainly by monocytes, fibroblasts, epithelial cells, 
and stromal cells from bone marrow and thymus. This cytokine is a stimulator of 
angiogenesis in vivo66. It induces T-cell proliferation and chemotaxis, promotes natural 
killer cell growth, the release of IFN-ɣ , granulocyte/macrophage colony stimulating 
factor and TNF-α and it co-stimulates B-cell growth and Ig production67. 
Although there is no evidence in the literature, IL-15 seems to include a miR-21 
binding site, which is complementary to the miR-21 seed sequence in the 3’ 
untranslated region (3’-UTR). 
 
Table 4 - Alignment of the IL-15 3’UTR with the miR-21 sequence, through MicroCosm 
Targets.  It provides the Ensembl gene accession, binding score, miRNA binding site, nucleotide 
starting and end of the mRNA binding site. 
Gene Name IL15 
Transcript ENST00000296545  
Gene ENSG00000164136  
Description Interleukin-15 precursor (IL-15). [Source:Uniprot/SWISSPROT;Acc:P40933] 
Hit 
infomation 
 
Rfam 
ID 
Score Energy Base P Poisson P Org P Start End Alignment 
hsa-
miR-
21 
15.782 -21 
4.859830e-
02 
4.743630e-
02 
4.743630e-
02 
403 425 
AGUUGUAG-UCAGACUAUUCGAu 
|||||| | |  |||:||:||| 
TCAACAGCTATGCTGGTAGGCTc 
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2.3. PTEN 
 
Phosphatase and tensin homolog (PTEN) has a tumor suppressor function and is 
known to be modulated by miR-21 both directly, through sites within its 3’UTR, and 
indirectly, through inhibition of Sprouty268. Targeting PTEN, miR-21 induces 
angiogenesis, through AKT and MAPK/ERK1/2 signaling pathways, increasing HIF-1α 
and VEGF expression40. In addition, PTEN controls cell migration and invasion, 
regulating MMP2 and MMP9, activity inhibited by the action of miR-2139. 
 
2.4. RECK 
 
It has been described that miR-21 promotes migration and invasion by targeting 
inhibitors of MMPs, one of which is Reversion-inducing cysteine-rich protein with Kazal 
motifs (RECK). RECK is a membrane-anchored glycoprotein, very important for normal 
development, that seems to have the ability to increase vessel formation within a 
matrix while maintaining vessel wall thickness. Thus, it has an essential role in 
angiogenesis69,70. 
 
2.5. RhoB 
 
Ras homolog gene family, member B (RhoB) is involved in intracellular trafficking 
of several proteins and it supports endothelial cell survival, morphogenesis, migration 
and angiogenesis. RhoB is described in literature to be a direct target of microRNA-21 
in its 3’UTR71,72,73. 
 
2.6. Spry1 and Spry2 
 
Sprouty (Spry) are membrane-anchored phosphoproteins that inhibit growth 
factor signaling in endothelial cells74. 
Sprouty1 (Spry1), an intrinsic inhibitor of the Ras/MEK/ERK pathway, was found 
in vascular endothelial cells and has been shown to inhibit vasculogenesis75. It also has 
an important role in the lineage specific differentiation of mouse embryonic stem cells 
(mESCs)76. Spry1 was found to be a miR-21 target in cardiac fibroblasts77. 
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Table 5 - Alignment of the Spry1 3’UTR with the miR-21 sequence, through MicroCosm 
Targets.  It provides the Ensembl gene accession, binding score, miRNA binding site, nucleotide 
starting and end of the mRNA binding site. 
Gene Name SPRY1 
Transcript ENST00000339241  
Gene ENSG00000164056  
Description Sprouty homolog 1 (Spry-1). [Source:Uniprot/SWISSPROT;Acc:O43609] 
Hit 
infomation 
 
Rfam 
ID 
Score Energy Base P Poisson P Org P Start End Alignment 
hsa-
miR-
21 
15.4735 -8.88 
6.613570e-
02 
6.399620e-
02 
8.139270e-
04 
401 422 
aguugUAGUCAGACUAUUCGAU 
     ||:: |:  |||||||| 
gtttaATTGCTTAAATAAGCTA 
 
MiR-21 is shown to directly target Sprouty2 (Spry2) in cardiocytes, promoting 
their proliferation and migration78. In addition, by repressing Spry2, this particular 
microRNA has a critical influence in the duration and magnitude of ERK-MAPK activity, 
being described to enhance the MSCs differentiation during osteogenesis79. 
 
Table 6 - Alignment of the Spry2 3’UTR with the miR-21 sequence, through MicroCosm 
Targets.  It provides the Ensembl gene accession, binding score, miRNA binding site, nucleotide 
starting and end of the mRNA binding site. 
Gene Name SPRY2 
Transcript ENST00000377104  
Gene ENSG00000136158  
Description Sprouty homolog 2 (Spry-2). [Source:Uniprot/SWISSPROT;Acc:O43597] 
Hit 
infomation 
 
Rfam 
ID 
Score Energy Base P Poisson P Org P Start End Alignment 
hsa-
miR-
21 
15.6224 -12.12 
5.701740e-
02 
5.542240e-
02 
4.753090e-
03 
222 243 
aguuGUAGUCAGACUAUUCGAU 
    |||   |:  |||||||| 
gaccCATGTATTGCATAAGCTA 
 
2.7. TSP-1 
 
Thrombospondin1 (TSP-1) is an ECM glycoprotein that inhibits angiogenesis 
naturally and acts like a tumor suppressor, activating the TGF-β signaling pathway80. 
Even though there is no evidence in the literature, in silico analysis reveals that 
TSP-1 contains a miR-21 binding site, which is complementary to the miR-21 seed 
sequence in the 3’ untranslated region (3’-UTR). 
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Table 7 - Alignment of the TSP-1 3’UTR with the miR-21 sequence, through MicroCosm 
Targets.  It provides the Ensembl gene accession, binding score, miRNA binding site, nucleotide 
starting and end of the mRNA binding site. 
Gene Name THBS1 
Transcript ENST00000260356  
Gene ENSG00000137801  
Description Thrombospondin-1 precursor. [Source:Uniprot/SWISSPROT;Acc:P07996] 
Hit 
infomation 
 
Rfam 
ID 
Score Energy Base P Poisson P Org P Start End Alignment 
hsa-
miR-
21 
17.4036 -22.72 
9.350550e-
03 
9.306970e-
03 
9.306970e-
03 
1248 1269 
agUUGUAGUCAGACUAUUCGAU 
  || |||||||| |||||||: 
ggAAAATCAGTCTAATAAGCTG 
 
 
Nevertheless, some of these predictions were confirmed by miRecords (Table 8) 
and miRDIP (Table 9), the chosen portals to cover all the applications for miRNA target 
predictions. 
 
 Table 8 - Angiogenesis related predicted targets for hsa-miR-21 through miRecords portal 
last updated at April 27, 2013. 5 targets were predicted (marked in blue) by at least 5 
algorithms. The NCBI accession number is provided as RefSeq for each predicted target. 
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Table 9 - Angiogenesis related predicted targets for hsa-miR-21 through miRDIP portal last 
updated in January, 2012. 6 targets were predicted by at least 4 algorithms. The NCBI 
accession number is provided as RefSeq for each predicted target. Also the respective 
database measure of confidence in the prediction (Score (origin)) is provided as well as a 
standardized score (score (std)), which allows the comparison between databases scores and 
ranges from 0 (least confident) to 100 (most confident). 
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 miR-21 modulation of its predicted targets 
 
In order to ascertain which of all these predicted targets are really modulated by 
the levels of miR-21, HUVECs from 3 different healthy individuals were transfected in 
the fourth passage with an anti-miR-21 inhibitor, a pre-miR-21 precursor and a 
scramble (Sc). Given the difficulty of isolation and maintenance of bone marrow 
endothelial cells (BMECs), HUVECs were chosen once these are the endothelial cells 
most commonly used in in vitro experiments. HUVECs, as primary endothelial cells, 
tend to lose their primary characteristics and responsiveness to various stimuli beyond 
the sixth passage. 
cDNA was synthesized from the extracted RNA and analyzed by RT-qPCR as 
described in methods section. 
 
RT-qPCR different approaches 
 
This quantitative assay measures the amount of cDNA during each amplification 
cycle of the PCR in real time, through the intensity signal of a fluorescent reporter 
molecule, in this case the Power SYBR® Green PCR master mix. It intercalates between 
double-stranded DNA (dsDNA), not discriminating dsDNA, including primer dimmers. 
ViiA™ 7 Real-Time PCR System software gives Ct (threshold cycle) values, which is 
the intersection between the amplification curve and a threshold line, being a relative 
measure of the target concentration. Through the mean of each technique replicate Ct 
values, it was possible to achieve the ∆Ct, normalizing Ct means in relation to the 
housekeeping genes. In a relative quantification, the analysis of changes in miRNA 
expression in a given sample relative to another reference sample (in this case the 
scramble) is preferentially given by ∆∆Ct, which compares ∆Ct values of the samples 
with a reference sample. Thus, there are several ways of representing the final results 
of a RT-qPCR. Some of the used RT-qPCR approaches are ∆Ct (Figure 7), 2-∆Ct (Figure 8), 
(2-∆Ct)/(2-∆Ct mean of the Sc) (Figure 9) that normalizes all the reference sample (Sc) 
values to 1, ∆∆Ct (Figure 10) and 2-∆∆Ct (Figure 11) that set all the reference sample (Sc) 
values as 0. 
Among the first 3 approaches of the same experiment (∆Ct, 2-∆Ct, (2-∆Ct)/(2-∆Ct 
mean of the Sc)) that are normalized only in relation to the housekeeping genes, a 
considerable difference is visible in their analysis, even if there are not significant 
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differences between the conditions (sc, anti-miR-21 and pre-miR-21). While in ∆Ct 
values representation (Figure 7), anti-miR-21 is reducing the miR-21 levels in the 
HUVECs and pre-miR-21 is slightly increasing them, 2-∆Ct (Figure 8) and (2-∆Ct)/(2-∆Ct 
mean of the Sc) (Figure 9) values representation transmit the very opposite. The same 
occurs between ∆∆Ct (Figure 10) and 2-∆∆Ct (Figure 11). So it can be concluded that 
exponential function (Y=2-x) seems to be masking the results, given that the higher 
value of X, the smaller value of Y. Therefore, the best approaches are ∆Ct and ∆∆Ct, 
once it’s the best approximation to the absolute values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 7 – miR-21 transfection efficiency represented by ∆Ct values. Error bars represent 
standard deviation (SD). 
 
F 
F 
F 
Figure 8 – miR-21 transfection efficiency represented by 2-∆Ct values. Error bars represent 
standard deviation (SD). 
 
Figure 9 – miR-21 transfection efficiency represented by 
Sc  theofmean  2
2
Ct
Ct
 values. Error 
bars represent standard deviation (SD). 
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Validation of mir-21 predicted targets 
 
The housekeeping genes are crucial for the estimation and comparison of mRNA 
levels. 18S, a part of ribosomal RNA, is a very abundant and stable housekeeping gene 
as it has a constant expression level across the samples. U6, in turn, is a small nuclear 
RNA (snRNA) is a good normalizer for the assessment of miRNA levels. Thus, in order 
to evaluate the miR-21 transfection efficiency, 18S and U6 were used as housekeeping 
genes, while in the analysis of the genes expression just 18S was used. 
In the first experiment, most probably because of the transfection failure (Figure 
12), pre-miR-21 precursor did not work (Figure 13), since all the predicted targets are 
more expressed in this condition than in the scramble. However, anti-miR-21 inhibitor 
slightly upregulated the expression of all the studied genes, improving significantly 
PTEN and RhoB gene expression. 
 
 
 
Figure 11 – miR-21 transfection efficiency represented by 2-∆∆Ct values. Error bars represent 
standard deviation (SD). 
 
Figure 10 – miR-21 transfection efficiency represented by ∆∆Ct values. Error bars represent 
standard deviation (SD). 
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In the second experiment and in contrast to anti-miR-21 inhibitor, pre-miR-21 
precursor transfection failed again (Figure 14). In addition, even though anti-miR-21 
inhibitor slightly increased the gene expression levels of all the other predicted targets, 
Figure 13 – Gene expression modulated by miR-21 levels for the first experiment. Only PTEN 
and RhoB were validated by the inhibition of miR-21 expression. Error bars represent standard 
deviation (SD). 
Figure 12 – miR-21 transfection efficiency in the first experiment. A) ∆Ct values 
representation; B) ∆∆Ct values representation, where Sc is the baseline (0). Error bars 
represent standard deviation (SD). 
A B 
Figure 14 – miR-21 transfection efficiency in the second experiment. A) ∆Ct values 
representation; B) ∆∆Ct values representation, where Sc is the baseline (0). Error bars 
represent standard deviation (SD). 
A  B 
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only RhoB, RECK, Annexin A1, IL-15 and Spry1 were significantly validated (Figure 15). 
Finally, in the third experiment, again in contrast to anti-miR-21 inhibitor that has 
slightly reduced miR-21 levels, pre-miR-21 precursor failed once again (Figure 16). 
Although the poor transfection efficiency, a small decrease of the miR-21 levels 
improves Jagged1, PTEN and Spry2 gene expression very slightly (Figure 17). 
All these experimental results cannot be easily compared once they are from 
primary cultures which were obtained from different donors and thus may have 
different phenotypes. HUVECs are also notoriously difficult to transfect and the 
transfection rate is of about 40%, as previously assessed in the laboratory, 
accompanied by a high percentage of cell death caused by the electroporation. 
Moreover, in the analysis of miRNA levels, the choice of 18S as housekeeping gene, 
beyond U6, may have been a problem because, as 18S is an rRNA very abundant, 
Figure 15 - Gene expression modulated by miR-21 levels for the second experiment. RhoB, 
RECK, Annexin A1, IL-15 and Spry1 were validated by the inhibition of miR-21 expression. Error 
bars represent standard deviation (SD). 
A      B 
Figure 16 - miR-21 transfection efficiency in the third experiment. A) ∆Ct values 
representation; B) ∆∆Ct values representation, where Sc is the baseline (0). Error bars 
represent standard deviation (SD). 
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amplifying rapidly, it might have exhausted the reaction reagents making the detection 
of rare miRNA products difficult or even impossible.  
As only PTEN and Spry2 had the most constant gene expression throughout 
these experiments, always being upregulated in the presence of reduced levels of miR-
21, they were confirmed in a fourth experiment. Pre-miR-21 transfection again failed, 
but anti-miR-21 inhibitor worked (Figure 18), supporting this validation experiment 
(Figure 19). Thus, it may be concluded that, besides PTEN, Spry2 is a miR-21 target in 
HUVECs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 - miR-21 transfection efficiency in the confirmation experiment. ∆Ct values 
representation. Error bars represent standard deviation (SD). 
Figure 17 - Gene expression modulated by miR-21 levels for the third experiment. Error bars 
represent standard deviation (SD). 
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Phenotypic changes modulated by miR-21 levels: Tube 
formation assay 
 
In order to assess the capacity of HUVECs with high and low levels of miR-21 to 
form a vascular network, a matrigel assay was performed (Figure 20) as described in 
methods section. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19 – Gene expression modulated by miR-21 levels for the confirmation experiment. 
Error bars represent standard deviation (SD). 
Figure 20 - Representative images of HUVEC tubules in growth factor-reduced Matrigel after 
transfection with anti-miR-21 inhibitor, pre-miR-21 precursor or scramble and culture for 24 
hours in the respective conditions (50 ng/ml VEGF and 5 ng/ml bFGF). 
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Transfection with anti-miR-21 inhibitor, in contrast to pre-miR-21 precursor, did 
not work (Figure 21) for this particular experiment and for this reason, tube formation 
was quantified for pre-miR-21 condition (Figure 22). Only the thinnest tubes were 
counted, due to the fact that the larger ones may have been formed simply by cell 
deposition and adhesion to the matrix. This quantification demonstrates that mir-21 
tends to increase tubulogenesis, in the presence of either angiogenic growth factor 
tested. Otherwise high levels of miR-21 seem to forfeit vascular network formation.  
 
  
A      B 
Figure 21 – miR-21 transfection efficiency for the matrigel assay. A) ∆Ct values 
representation; B) ∆∆Ct values representation, where Sc is the baseline (0). Error bars 
represent standard deviation (SD). 
Figure 22 – Quantification of tube formation by transfected HUVECs in the presence of VEGF 
or bFGF. Error bars represent standard deviation (SD). 
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Phenotypic changes modulated by miR-21 levels: Cell 
migration assay 
 
Cell migration was assessed through the “wound healing/scratch” assay as 
described in methods section. It is a simple and economical technique, in which upon 
creation of a gap called “scratch” on a confluent cell monolayer, the cells on the edge 
of the newly created gap will move toward the denuded area to close the wound until 
the cell-to-cell contacts are reestablished (Figure 23), similarly to migration of cells in 
vivo. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23 – Representative images of HUVEC migration capacity after transfection with anti-
miR-21 inhibitor, pre-miR-21 precursor and scramble. Also the control without treatment is 
represented. 
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For the cell migration quantification, the condition in which miR-21 is 
overexpressed was not taken into account due to the transfection failure (Figure 24). 
For each of the other conditions, wound thickness was measured in different time 
points (Figure 25). Transfected HUVECs did not migrate clearly, in contrast to non 
treated cells that had already completely closed the wound after 12 hours. This is 
suggestive of transfection itself affecting cell migration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24 – miR-21 transfection efficiency for the scratch assay. ∆Ct values representation. 
Error bars represent standard deviation (SD). 
Figure 25 – Quantification of transfected HUVEC migration throughout time. 
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Endothelial-specific miR-21 KO mice generation 
 
In order to evaluate miR-21 functions specifically on endothelial cells, we 
considered it would be very useful to generate endothelial-specific miR-21 knock-out 
(KO) mice to compare with wild type (WT) mice. 
Therefore, miR-21 KO mice are being generated applying the bacteriophage P1-
derived Cre/loxP recombination system to C57 Bl6 miR-21 conditional knock-out 
mice81,82. 
This system is highly effective and involves the Cre (cyclization recombination) 
enzyme, a type I topoisomerase that catalyzes the recombination between two loxP 
(locus of X-over of P1) sites, specific 34-base pair sequences that flank the gene coding 
region and 3’UTR in the conditional knock-out mice. These sites are acquired by 
homologous recombination in embryonic stem cells. Each loxP site comprises an 
asymmetric 8-base pair central spacer region that allows the recombination and 
confers directionality, flanked by two 13-base pair inverted repeats where Cre binds 
Figure 26 – Schematic representation of the Cre/lox recombination system. A) WT lox P 
sequence. The asymmetric spacer region states the direction of the lox P sequence, as 
showed by the arrow.  b) Recombination between 2 lox P sites with the same direction. C) 
Recombination between 2 lox P sites in the opposite direction. Adapted from Morozov A. 
Controlled Genetic Manipulations. (1st edition). Humana Press, 2012. 
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to. The fusion of both loxP sites may result in excision, inversion or integration 
depending on the location and relative orientation of the loxP sites (Figure 26)81,82. 
To achieve tissue-specific knock-out of a gene, a tissue-specific promoter is 
recommended to be associated with the Cre transgene. For instance, vascular 
endothelial-cadherin (VE-Cadherin) promoter is required to have Cre expression 
specifically in endothelial cells under the regulatory control of VE-Cadherin81,82. 
Furthermore, for this system to be inducible, it makes use of a ligand-dependent 
chimeric Cre recombinase, called CreERT2 recombinase83, which is a Cre fused with a 
mutated (G400V/M543A/L544A triple mutation) hormone-binding domain of the 
estrogen receptor (ER). Thus, it only will be active after treating mice with tamoxifen 
that is metabolized to the synthetic ER ligand 4-hydroxytamoxifen (OHT), which binds 
with high affinity to the ER ligand-binding domain of CreERT2 recombinase. The 
inducibility of this system allows external temporal Cre activity, limiting unwanted Cre 
activity and related side-effects82. 
The generation of genetically modified mice is assured by mice genotyping, 
which is designed to detect sequences in the murine genome by PCR amplification. 
For this purpose, a set of PCR conditions has been developed to identify a 
detectable amplimer with any primers from sequences present only in a single copy in 
the genome. These primers must be about 30 nucleotides in length with approximately 
50% guanosine or cytosine and they should not have homologous three prime ends, 
repetitive sequences or long runs of a single residue, while the amplimer must be 100-
400 nucleotides in length, noting that shorter sequences amplify better82. 
So, firstly, miR-21 conditional KO mice were confirmed to be conditional (miR-
21lox/lox mice) after some mice genotyping protocol optimizations. Several PCR 
conditions varying reagents quantities and annealing temperatures were tried, but 
only without lysis buffer and with the usual 0,5 µl of MgCl2 at 60ºC (Figure 27) was 
1    2     3    4     5    6     7    8     9   10  11  12   13  14  15 
Negative Control Samples Positive Control 
Figure 27 – Mice genotyping optimization test with various conditions at 60ºC. (1-5) 
Negative Control; (6-10) Sample; (11-15) Positive Control. (1,6,11) without lysis buffer with 
0,25µl 40mM MgCl2/sample; (2,7,12) 5µl lysis buffer with 0,25µl 40mM MgCl2/sample; (3,8,13) 
(3,8,13) 5µl lysis buffer without MgCl2; (4,9,14) without lysis buffer with 0,5µl 40mM 
MgCl2/sample; (5,10,15) 10µl lysis buffer without MgCl2. 
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possible to genotype these mice (Figure 28). 
In miR-21lox/lox mice genotyping, a WT allele is expected to have 230 pb while a 
floxed one is estimated to have 306 pb, as it includes the loxP site (Figure 29). CreERT2+ 
mice were also achieved by the deletion of floxed alleles of Dll4 conditional KO mice 
throughout some crosses between these and WT mice till obtain CreERT2+ mice WT for 
Dll4. 
During mice genotyping, some differences were observed among the stains 
(Figure 30). EtBr has been chosen as the stain for nucleic acids, since it is very sensitive 
and stable. Despite that, it is a very cytotoxic and potent mutagen. GelRed, by 
contrast, is not cytotoxic neither mutagenic and it is designed to be impenetrable to 
latex gloves and even cell membranes. Though, while EtBr forms a straight band, 
GelRed seems to form a distorted one, which may difficult the interpretation of results 
when there is a very small distance between the bands (Figure 30). 
 
 
A 
 
B 
Figure 30 – Mice genotyping results obtained with (A) EtBr or (B) GelRed. 
Figure 29 – Schematic representation of the genotyping PCR approach. The positions of the 
used primers are indicated by the arrows. 
Figure 28 - miR-21lox/lox mice genotyping. NC – Negative Control; PC – Positive Control. 
 NC    PC       1       2       3       4        5       6        7       8 
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Once genotyped, these mice were bred together and then the resultant miR-
21lox/lox CreERT2+ mice were selected and mated to be then induced by tamoxifen. 
This procedure will give rise to endothelia miR-21 KO mice. These homozygous 
mutant mice present no overt abnormalities. Moreover, they exhibit less susceptibility 
to lung tumorigenesis due to K-ras activation through the upregulation of several 
antagonists of the Ras/MAP kinase signaling pathway84. 
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Conclusions 
 
In this study, it was demonstrated that HSCs express significantly less miR-21 
than committed cells in general, including endothelial cells. 
Moreover, bioinformatics approaches and literature allowed to choose 9 miR-21 
predicted targets for further validation, namely Jagged1, annexin A1, IL-15, PTEN, 
RECK, RhoB, Spry1, Spry2 and TSP-1. Despite all these putative targets, only PTEN and 
Spry2 were validated to be modulated by the inhibition of miR-21 in HUVECs. Even so, 
there are indications of other predicted targets, whose levels seem to be determined 
by the reduction of miR-21 levels in these cells, such as Jagged1 and RhoB. However, 
the techniques employed for the validation of miR-21 predicted targets have had little 
success. This might be explained by the variation between HUVECs with different 
donor origin, the difficulty to transfect HUVECs or by the low transfection efficiency 
itself. It also can be explained by a possible exhaustion of the reaction reagents caused 
by the natural abundance of the housekeeping gene 18S, as well as the simple fact that 
miRNAs are particularly difficult to manage and to amplify due to their reduced size 
and rarity. 
Furthermore, it was demonstrated that miR-21 tends to increase the formation 
of a vascular network in the presence of growth factors (VEGF or bFGF). In their 
absence, miR-21 appears to have the reverse effect. As regards the cell migration, no 
conclusions about miR-21 modulation were reached, because transfection seems to be 
affecting cell migration. 
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